Calcium (Ca)
Calcium is the main mineral your bones and teeth are built from — about 1 kg of it stored in the skeleton — and is also essential for muscle contraction, nerve signalling, and blood clotting. UK NHS guidance recommends 700 mg/day for adults (rising to 1,000 mg/day for breastfeeding women), and most UK adults can meet this from food alone if their diet includes dairy, fortified plant drinks, leafy greens, tinned fish with bones, or fortified bread and breakfast cereals. Two practical things to know when comparing supplements: 1. What "1,000 mg calcium" actually delivers depends on the form. Calcium carbonate is the cheapest and most concentrated (40% elemental calcium — so a 1,000 mg carbonate tablet gives you 400 mg of actual calcium). Calcium citrate is better absorbed if you're on a PPI like omeprazole or you're older with reduced stomach acid, but you need more tablets for the same calcium dose. 2. Your body can only absorb about 500 mg of calcium at one time. Splitting the dose (morning + evening) gives better absorption than one big dose. UK NICE pathway for bone-fracture prevention (CG146) supports calcium + vitamin D supplementation for postmenopausal women and older adults with low dietary intake. For most other adults, food-first is the right answer. Pregnancy: 700 mg/day is the same as the adult RNI. Talk to your midwife or GP about supplementation if your diet is low.
Camden Medicals editorial · Last reviewed 12 June 2026 · Next review June 2027
- Cross-checked against
- NHS
- NICE
- BNF
- EFSA
- FSA
Camden's editorial team independently graded each health claim below on the strength of the published evidence — see the grade beside every condition.
- Class
- Mineral
- Typical daily dose
- UK supplements typically deliver 200-600 mg elemental calcium per serving. Bone-protective indications under NICE guidance (e.g. alongside bisphosphonate therapy) typically use 1000 mg/day total elemental calcium plus 800 IU vitamin D, with diet making up part of the total. Single-dose absorption saturates above ~500 mg elemental — split-dose 2×500 mg achieves better total uptake than a single 1000 mg dose.
- Top use evidence
- Strong
On this page
What it is
Calcium is the most common mineral in your body — about a kilogram of it in an average adult, almost all of it locked into the structure of bones and teeth. The remaining 1% circulates in your blood and inside cells, where it has critical jobs: triggering every muscle contraction (including your heart), helping nerves talk to each other, helping blood clot when you cut yourself.
UK food sources you'll meet your daily 700 mg from:
- Dairy — milk, yoghurt, cheese (200-300 mg per serving)
- Fortified plant drinks — UK oat / almond / soya milks are fortified to roughly the same calcium content as dairy milk (~120 mg per 100 ml)
- Leafy greens — kale, broccoli, pak choi. Spinach is high in total calcium but most of it is bound by oxalate and not well absorbed.
- Tinned fish with bones — sardines, salmon
- Fortified bread and breakfast cereals — a routine UK contributor most people forget
- Almonds, sesame seeds
Supplement forms you'll see on UK shelves:
Calcium carbonate — the most common; 40% elemental calcium so the most concentrated. Cheapest. Take with food because absorption needs stomach acid. Not ideal if you take a long-term PPI like omeprazole.
Calcium citrate — 21% elemental calcium. Better absorbed if you take a PPI, are older, or had gastric surgery. More tablets to swallow for the same calcium dose. Often more expensive.
Calcium hydroxyapatite — bone-meal-derived. Marketed as "more bioavailable" but the trial evidence is mixed. Check the supplier for heavy-metal testing — older bone-source preparations had lead-contamination concerns.
Calcium lactate / gluconate — less concentrated still. Useful if you have GI side effects from carbonate.
UK supplements are typically 200-600 mg elemental calcium per serving, often combined with vitamin D3 (for absorption) and sometimes vitamin K2 (for directing calcium to bones rather than soft tissue).
At a glance
- UK NHS RNI is 700 mg/day for adults (1,250 mg/day when breastfeeding). Most UK adults can meet this from food — dairy, fortified plant drinks, leafy greens, tinned fish with bones, and fortified bread or cereal.
- Read the ELEMENTAL calcium figure, not the total salt weight: a "1,000 mg calcium carbonate" tablet provides about 400 mg of actual calcium. Carbonate is cheap and taken with food; citrate is better absorbed if you take a PPI such as omeprazole.
- Absorption is best in amounts up to about 500 mg at a time, so a split 2 × 500 mg is taken up better than a single 1,000 mg dose.
- Separate calcium by 2-4 hours from levothyroxine, tetracycline or fluoroquinolone antibiotics, bisphosphonates, and iron supplements, which bind to it in the gut. UK NICE supports calcium supplements where dietary intake is low or bone-protective treatment is indicated — not as a routine supplement for everyone.
What people use it for
UK adults whose dietary calcium intake is below the 700 mg/day RNI
Where dietary calcium intake is genuinely below RNI (vegan diet without fortified plant drinks, lactose-intolerance without alternative dairy substitution, low-energy diets), supplementation can close the gap. The first step should be a NHS Eatwell-Guide-aligned diet-review — most UK adults can meet calcium intake from diet without supplements. UK NICE clinical knowledge summaries on osteoporosis prevention (CKS) include calcium and vitamin D supplementation when dietary intake is low and bone-protective treatment is indicated. [3,1]
Some evidenceStrongPostmenopausal women with established osteoporosis or osteopenia
NICE guidance for fragility-fracture prevention (CG146 / CKS osteoporosis) supports calcium plus vitamin D supplementation alongside bisphosphonate or other bone-protective drug treatment, where dietary intake is below 700 mg/day. The Article 14 reduction-of-disease-risk claim ("Calcium and vitamin D help to reduce the loss of bone mineral in postmenopausal women") applies at specific dose thresholds. This is a clinical indication — work with the GP managing the bone-health pathway. [2,3]
Some evidenceStrongAdults on long-term proton pump inhibitor (PPI) therapy
Long-term PPI therapy reduces stomach acid and impairs absorption of calcium carbonate (which requires acid for dissolution and ionisation). Calcium citrate is absorbed independently of stomach acid and is the preferred form in this context. PPI use also has a separate weak association with reduced fracture-resistance — discuss with the GP managing the PPI prescription whether a periodic review or step-down is appropriate. [5]
Some evidenceModerateAdults exploring calcium for cardiovascular health
There is no UK-recognised cardiovascular pathway that recommends calcium supplementation in the absence of a bone-health indication. The 2010 Bolland et al. BMJ meta-analysis raised concerns about a small absolute increase in MI risk with calcium-only (not calcium-plus-vitamin-D) supplementation; the literature is mixed and subsequent analyses of the Women's Health Initiative did not replicate the effect. UK NICE NG238 (cardiovascular risk reduction) does NOT recommend routine calcium supplementation. Dietary calcium has not been associated with the same signal. [4]
Popular, not provenMixedPregnant or lactating women
UK pregnancy RNI for calcium is 700 mg/day (no increase from non-pregnant adult). UK lactation RNI is 1,250 mg/day. NHS pregnancy nutrition guidance is to meet calcium needs from diet — milk, yoghurt, cheese, fortified bread, fortified plant drinks. Calcium-deficient diets in pregnancy are associated with maternal bone-mineral loss; the routine UK pregnancy supplement profile (folate, vitamin D) does not include calcium except where dietary intake is inadequate. Talk to the midwife or GP if your diet is low in calcium sources. [10]
Some evidenceStrong
How it works
Your bones aren't static storage. They're constantly being broken down and rebuilt, with calcium moving in and out of bone mineral every day. When you're a child or teenager, more is going in than out, building up to peak bone mass in your early 20s. After menopause in women and from around age 70 in men, more is going out than in — which is why the postmenopausal bone-loss period is where calcium supplementation has clear UK NICE pathway support.
Calcium absorption from the gut depends on vitamin D. The active form of vitamin D switches on the proteins in your intestinal lining that pull calcium across into the bloodstream. If your vitamin D is low, you absorb less of the calcium you eat — which is why the two are routinely supplemented together for bone health.
Once calcium is in your bloodstream, three hormones keep its level within a tight range: parathyroid hormone (PTH) from the four small glands behind your thyroid (raises blood calcium by pulling it out of bones if needed); calcitriol (active vitamin D, makes you absorb more from food); and calcitonin (lowers blood calcium when it's too high). This is why blood calcium stays remarkably stable even if your dietary intake varies day-to-day — the body is constantly buffering it from the bone reservoir.
A second axis worth knowing about is the calcium-vitamin-K2 link. Two proteins in your body — osteocalcin and matrix Gla protein — direct calcium into bone where it belongs AND keep it OUT of arteries where it doesn't. Both proteins need vitamin K2 to work properly. This is the basis for the increasingly common D3 + K2 combination supplements with calcium: K2 helps your body put calcium in the right place. The trial evidence on hard cardiovascular endpoints from this combination is still developing — promising mechanism, still maturing data.
The cardiovascular debate: a 2010 BMJ meta-analysis (Bolland and colleagues) suggested that high-dose calcium-only supplements might modestly increase heart-attack risk. Subsequent UK NICE and NHS guidance responds to this signal by recommending calcium supplements only where dietary intake is genuinely low or there's a clinical bone-protective indication — not as a routine over-the-counter add-on. Dietary calcium from food has NOT been associated with this signal.
Common myths
Myth""More calcium is better for bones.""
RealitySingle-dose calcium absorption saturates above approximately 500 mg elemental calcium — taking 1000 mg in one go does not deliver double the absorbed dose. Split dosing (e.g. 2 × 500 mg) achieves better total uptake. Total daily intake above the EFSA tolerable upper intake (2500 mg/day from food plus supplements) increases the risk of hypercalcaemia, kidney stones, and possibly cardiovascular events with supplemental (not dietary) calcium.
Myth""Calcium supplements work the same as dairy.""
RealityBioequivalent total elemental calcium yes; matrix-bioactive no. Dairy delivers calcium alongside protein, phosphate, vitamin D (in fortified products), bioactive peptides, and whole-food matrix. Supplements deliver calcium alone (or with a few co-factors). Trial outcomes for dairy-derived calcium and supplemental calcium are not always interchangeable; UK NHS guidance places dairy or fortified-plant-drinks above supplements as the first-line calcium source. [1]
Myth""Coral calcium is special / different / superior.""
RealityCoral calcium and oyster-shell calcium are chemically calcium carbonate — the same form as the cheapest pharmacy-counter calcium tablet. Marketing language ("ionised", "marine-source", "natural mineral matrix") does not change the underlying chemistry. Marine-source calcium also has historic heavy-metal contamination concerns (lead, particularly) — look for an explicit heavy-metal screen on the spec sheet.
Myth""Spinach is a great calcium source.""
RealitySpinach has high total calcium content but the calcium is bound by oxalate, which substantially reduces absorbability — net bioavailable calcium from spinach is roughly 5%, compared to ~30% from milk and ~50%+ from broccoli or kale. Other dark leafy greens (kale, pak choi, broccoli) are good sources; spinach is not. [1]
Myth""You can't overdose on calcium because the body just excretes it.""
RealityNot true. EFSA tolerable upper intake is 2500 mg/day from food plus supplements. Above this, hypercalcaemia, milk-alkali syndrome, kidney-stone risk, and (debated) cardiovascular signals appear in the literature. The body regulates plasma calcium narrowly; sustained excess intake taxes that regulation and is not benign.
What people say online
Calcium discourse on TikTok and Reddit splits across three clusters: bone-health / osteoporosis-prevention content (typically NHS / NICE-aligned), the "calcium gives you heart attacks" cluster (driven by older Bolland 2010 BMJ meta- analysis content), and the "K2 + D3 + calcium" biohacker cluster (mechanism-strong, trial-evidence-still-developing). UK consumers are particularly well-served by NHS calcium content; the cardiovascular debate gets sensationalised on US-clinic content. This section surfaces the discourse without naming individuals.
Trending claims
- TikTok + Reddit (older Bolland-derived content)high visibility
Claim: Calcium supplements cause heart attacks
Reality check: The 2010 Bolland BMJ meta-analysis raised a signal that calcium-only supplements (without vitamin D) might modestly increase heart-attack risk. Subsequent meta-analyses (Ford 2014, PMID 25057156) did not consistently replicate this when calcium was given with vitamin D. The UK NICE position has narrowed: calcium supplements are appropriate where dietary intake is inadequate OR where bone-protective treatment is indicated — not as a routine over-the-counter add-on for all adults. Dietary calcium from food has not been associated with the signal. [9]
- TikTok (high-dose supplementation content)medium visibility
Claim: More calcium is better — take 1,500 mg / day
Reality check: NO. UK NHS RNI is 700 mg/day for adults; EFSA upper intake is 2,500 mg/day from diet plus supplements combined. Single-dose absorption saturates above 500 mg elemental — a 1,000 mg single dose absorbs only modestly more than 500 mg. Sustained high-dose calcium increases risks of hypercalcaemia, kidney stones, and (debated) cardiovascular events. Pick a UK NHS-aligned target dose + meet most of it from diet.
- TikTok + general wellness contenthigh visibility
Claim: Just take calcium and vitamin D — that's all your bones need
Reality check: Calcium + vitamin D is well-evidenced for bone-fracture prevention in older adults (Avenell 2014 Cochrane n=91,791, PMID 24729336) — but that doesn''t make supplementation appropriate for everyone. UK NHS food-first guidance: dairy, fortified plant drinks, leafy greens, tinned fish, fortified bread / cereal can meet 700 mg/day for most adults. Weight-bearing exercise, vitamin D status (UK NHS recommends 10 µg/day October-March year-round for some groups), and not smoking matter as much as supplemental calcium. [8]
- TikTok + Reddit (supplement-form content)medium visibility
Claim: Calcium carbonate is fake — buy citrate
Reality check: Both forms work. Calcium carbonate (40% elemental) is cheap, well-absorbed when taken with food, and the form used in most UK low-cost supplements. Citrate (21% elemental) is better-absorbed if you take a PPI (omeprazole, lansoprazole) or have reduced stomach acid from age. Carbonate is NOT inferior — it''s the right choice for most adults; citrate is the right choice in specific contexts.
Where the conversation lives
- TikTok hashtags: #calcium, #bonehealth, #osteoporosis, #d3k2
- Reddit subs: r/Supplements, r/Osteoporosis, r/Menopause, r/Nutrition
- Forums: Examine.com (paid analysis), Healthline UK
Questions people are searching
- Do I need a calcium supplement?
- Calcium carbonate vs calcium citrate — which is better?
- How much calcium can my body actually absorb at once?
- Is calcium supplementation safe for my heart?
- When should I take calcium with vitamin D?
Who drives the discourse: The discourse is driven by three influencer classes: nutritionist / dietitian creators (most NHS-aligned; clear on food-first); menopause / women''s-health creators (focused on bone-loss prevention); biohacker / longevity creators (D3 + K2 + magnesium + calcium "bone stack" framing). Verifera editorial does not name individuals.
Social-media trends change quickly. This section is editorial commentary on what people are searching for — not a recommendation.
Common online questions
Synthesised from the questions UK shoppers most often ask online about Calcium (Ca). Each answer is editorial and links to its evidence in the Sources list below.
How much calcium do I actually need?
UK adults: 700 mg/day (Reference Nutrient Intake). Pregnant: 700 mg/day (no increase). Breastfeeding: 1,250 mg/day. UK NRV used for label % is 800 mg/day. Most UK adults can meet this from diet — milk and dairy, fortified bread, fortified plant drinks, leafy greens, tinned fish with bones. NHS Eatwell Guide is the dietary anchor. [1]
Calcium carbonate or calcium citrate — which?
Calcium carbonate is cheapest and most concentrated (40% elemental calcium) but needs stomach acid to dissolve — take it with food. Calcium citrate is 21% elemental calcium so requires more pills for the same dose, but is absorbed independently of stomach acid — preferred if you take a long-term proton pump inhibitor (omeprazole, lansoprazole, pantoprazole), have achlorhydria (older adults), have had gastric bypass, or get GI side effects on carbonate.
Should I take calcium with my levothyroxine?
Separate by at least 4 hours. Calcium chelates levothyroxine and reduces its absorption — taking them together can produce sub-therapeutic thyroid replacement. Standard advice is levothyroxine on rising on an empty stomach, calcium with a later meal. The same separation rule applies to bisphosphonate osteoporosis tablets. [11]
Do calcium supplements cause heart attacks?
The 2010 Bolland et al. BMJ meta-analysis raised this concern; subsequent literature is mixed. UK NICE does not recommend routine calcium supplementation for cardiovascular prevention. The honest position: where calcium supplementation is clinically indicated (low dietary intake plus a bone-health concern), co-prescription with vitamin D is the standard pathway and the cardiovascular signal in the original meta-analysis was specific to calcium-only supplementation. Dietary calcium has not been associated with the same signal. [4]
Can I take calcium and iron together?
Separate by 2 hours. Calcium and iron compete for absorption at the same intestinal transporters. Standard practical advice is iron in the morning on an empty stomach (with vitamin C to aid absorption), calcium with a later meal — particularly important if you are managing diagnosed iron-deficiency anaemia. [12]
Is the calcium in plant milk really equivalent to cow's milk?
For most UK plant drinks, yes — they are typically fortified to approximately 120 mg calcium per 100 ml, matching cow''s milk. Watch for unfortified organic plant drinks which may contain very little calcium. Check the back-of-pack nutrition panel. [1]
UK regulatory landscape
UK regulatory tier: Food supplement
Calcium is regulated under the UK Food Supplements Regulations 2003. Multiple Article 13.1 authorised health claims permit descriptive wording for bones, teeth, muscle function, neurotransmission, blood clotting, energy-yielding metabolism, digestive enzyme function, and cell division. The Article 14 reduction-of-disease-risk claim for calcium + vitamin D in postmenopausal women is also authorised. The UK NICE CG146 + CKS Osteoporosis Prevention pathway treats supplementation as a clinical intervention where dietary intake is inadequate or a bone-protective indication exists.
What crosses the tier
| Condition | Crosses to |
|---|---|
| Marketing for osteoporosis treatment without prescriber oversight | Crosses to medicinal claim. NICE pathway is GP-led bone-protective treatment (bisphosphonate ± calcium ± vitamin D). |
| Marketing as cardiovascular-disease prevention | Outside register wording; debated cardiovascular safety signal (Bolland 2010) limits the framing. |
| Marketing for routine high-dose supplementation >2,500 mg/day total | Above EFSA tolerable upper intake; increased risk of hypercalcaemia, kidney stones, milk-alkali syndrome. |
Permitted claims
Multiple Article 13.1 authorised claims (bones, teeth, muscle, neurotransmission, clotting, energy-yielding metabolism, digestive enzymes, cell division). Article 14 disease-risk- reduction claim for calcium + vitamin D in postmenopausal women authorised. NOT permitted: osteoporosis treatment claims, cardiovascular-prevention claims, cancer-prevention claims, claims for clinical hypocalcaemia management.
Cross-jurisdiction note
Calcium dietary reference values vary internationally (US RDA 1,000-1,200 mg/day vs UK 700 mg/day for adults). The UK lower target reflects different population-level intake patterns and dietary calcium adequacy from food. US-focused supplement marketing routinely recommends higher doses than UK NICE / NHS pathways.
UK regulatory rules evolve. This summary is editorial — businesses should consult regulatory counsel; consumers should consult their pharmacist or GP.
🔬 Camden’s evidence review
The research Camden reviewed, graded on its strength. This is our own appraisal — it sits beneath the official guidance above, never above it.
Bone-mineral density and fragility fracture prevention — postmenopausal women on bone-protective drug treatment
StrongEvidencestrongCalcium 1000 mg/day plus vitamin D 800 IU/day is the UK NICE- recommended adjunct to bisphosphonate or other bone-protective treatment in postmenopausal osteoporosis where dietary calcium is below 700 mg/day. The Article 14 disease-risk-reduction claim text — "Calcium and vitamin D help to reduce the loss of bone mineral in postmenopausal women. Low bone mineral density is a risk factor for osteoporotic bone fractures" — applies at specific dose thresholds. Calcium-without-vitamin-D supplementation in community-dwelling postmenopausal women without bone-protective drug treatment has not consistently reduced fragility fracture rate in trials. [2,3]
Cardiovascular safety of calcium supplementation
MixedEvidencemixedBolland 2010 BMJ meta-analysis suggested a small absolute increase in myocardial infarction risk with calcium-only supplementation (not calcium-plus-vitamin-D) in older adults. Subsequent reanalyses of the Women''s Health Initiative and other cohorts have not consistently replicated the signal. UK NICE NG238 does not recommend routine calcium supplementation for cardiovascular disease prevention; the position has been: prescribe calcium where bone-health indication exists with concomitant vitamin D, not as a stand-alone cardiovascular intervention. Dietary calcium has not been associated with the cardiovascular signal. [4]
Kidney stones
ModerateEvidencemoderateCalcium oxalate is the most common kidney-stone composition. Counter-intuitively, low dietary calcium intake increases stone risk because dietary calcium binds oxalate in the gut and reduces oxalate absorption — Curhan 1997 (NEJM, NHS-1) showed dietary calcium intake inversely associated with kidney-stone risk. Supplemental calcium taken APART from meals does NOT have the same gut-oxalate-binding effect and has been weakly associated with INCREASED stone risk in some cohorts. Practical implication: if calcium supplements are clinically indicated, take them with a meal where possible. [13]
Pre-eclampsia prevention in women with low calcium intake
ModerateEvidencemoderateWHO recommendation supports calcium supplementation (1.5-2 g/day) in women with low dietary calcium intake from mid-pregnancy to reduce pre-eclampsia risk. UK pregnancy diets are typically not in this low-intake category and routine UK pregnancy supplement practice does not include calcium. Hofmeyr 2018 Cochrane review (CD001059) supports the WHO position in low-intake settings. [14,7]
Muscle cramp / restless-leg / "calcium tetany" supplementation
InsufficientEvidenceinsufficientRoutine calcium supplementation for muscle cramps in adults with normal serum calcium has insufficient trial evidence. Frank symptomatic hypocalcaemia produces tetany, perioral paraesthesia, and Chvostek / Trousseau signs — these are clinical findings requiring GP investigation, not self-supplementation indications.
Clinical literature review
The calcium literature centres on two main questions: bone- fracture prevention and cardiovascular safety. The Avenell 2014 Cochrane systematic review (PMID 24729336, 53 trials, n=91,791) is the definitive evidence base for fracture prevention — vitamin D alone unlikely to prevent fractures, vitamin D plus calcium produces small but significant reduction in hip-fracture risk (RR 0.84 in older adults). The Ford 2014 Am J Clin Nutr meta-analysis (PMID 25057156) covered cardiovascular endpoints in the linked RECORD trial and 21 other RCTs — vitamin D plus calcium did not increase cardiovascular events, though earlier Bolland 2010 BMJ analyses had raised a calcium-only signal that influenced UK NICE pathway narrowing. UK NICE CG146 (Osteoporosis: assessing the risk of fragility fracture) and CKS Osteoporosis Prevention support calcium + vitamin D supplementation where dietary intake is inadequate and bone-protective indication exists. Routine calcium supplementation for otherwise-healthy adults is NOT in UK NICE pathways.
Key trials
Avenell A et al. · 2014 · Cochrane Database Syst Rev · PMID 24729336
Finding: Vitamin D + calcium reduces hip-fracture risk in older adults (RR 0.84, 95% CI 0.74-0.96; nine trials n=49,853). In community-dwelling adults the absolute effect is modest (one fewer hip fracture per 1,000 per year); in institutionalised adults (higher baseline risk) the effect is larger (nine fewer hip fractures per 1,000 per year). Vitamin D alone, in the formats and doses tested, did NOT prevent fractures. Small increase in gastrointestinal symptoms and renal disease with supplementation.
Relevance: The definitive evidence base for bone-protective calcium + vitamin D supplementation. Anchors the UK NICE CG146 and CKS Osteoporosis pathway recommendations.
Ford JA et al. · 2014 · Am J Clin Nutr · PMID 25057156
Finding: Vitamin D supplementation might protect against cardiac failure in older people (HR 0.75, 95% CI 0.58-0.97 in the RECORD trial; pooled HR 0.82 in the meta-analysis) but does not appear to protect against myocardial infarction or stroke. Did NOT confirm the earlier calcium-cardiovascular harm signal at the meta-analytic level — the question remains debated.
Relevance: Contemporary evidence on the cardiovascular safety of vitamin D + calcium supplementation. Counterbalances the earlier Bolland 2010 BMJ signal that drove UK NICE to narrow routine calcium supplementation recommendations.
Systematic reviews
- pmid:24729336
Avenell 2014 Cochrane n=91,791 — vitamin D + calcium produces small but significant hip-fracture reduction in older adults. Effect-size is larger in higher-risk (institutionalised) populations. Anchors UK NICE bone- pathway recommendations.
Evidence quality summary
Bone-fracture prevention with calcium + vitamin D in older adults — HIGH certainty (Avenell 2014 Cochrane n=91,791). Calcium alone for fracture prevention — LIMITED certainty. Cardiovascular safety of supplemental calcium — DEBATED (Bolland 2010 raised a signal; Ford 2014 + later trials did not consistently replicate; UK NICE position has narrowed routine supplementation accordingly). Pregnancy supplementation where dietary intake adequate — INSUFFICIENT certainty for routine use (WHO advises in low-dietary-calcium settings; not a UK NICE pathway). Dietary calcium for bone health — HIGH certainty (foundational nutrition science).
Known gaps
- Head-to-head trials of different calcium forms (carbonate vs citrate vs hydroxyapatite) at matched elemental dose are limited.
- Long-term safety data on vitamin K2 + calcium + D3 combination supplements (the modern "bone stack") is still maturing.
- Cardiovascular signal at calcium-only vs calcium+D3 supplementation — meta-analyses disagree; ongoing question.
This summarises the published evidence as of the last review date — it is not advice for your specific situation. Talk to your pharmacist or GP.
Safety
Calcium is one of the safer minerals at dietary and standard supplement doses. Most UK adults meet calcium needs from diet without supplementation. Where supplementation is appropriate, attention to elemental dose, form, drug-separation timing, and EFSA upper intake is enough to avoid the realistic risks (hypercalcaemia, kidney stones, drug-absorption interference).
Talk to your pharmacist or GP first if you:
- You take levothyroxine, a tetracycline antibiotic, a fluoroquinolone antibiotic, a bisphosphonate, or iron supplements — separate by at least 2-4 hours.
- You take a thiazide diuretic (bendroflumethiazide, indapamide) — calcium retention is increased; high-dose supplementation can produce hypercalcaemia.
- You take lithium — risk of hypercalcaemia.
- You take digoxin — high serum calcium potentiates digoxin cardiac effects; sustained high-dose calcium not advisable.
- You have chronic kidney disease, hyperparathyroidism, sarcoidosis, or any condition causing hypercalcaemia — calcium supplementation is contraindicated without renal / specialist input.
- You have a history of kidney stones — take calcium with meals (gut-oxalate binding) and not as a high-dose isolate; separate from oxalate-rich foods.
- You are pregnant or breastfeeding — meet calcium needs from diet; supplementation only if dietary intake is inadequate.
Common side effects: Constipation, GI bloating, stomach upset (more common with carbonate). Hypercalcaemia, kidney stones, milk-alkali syndrome at very high doses or in renal impairment.
Pregnancy and breastfeeding
UK pregnancy RNI for calcium is 700 mg/day — the same as non-pregnant adults. Routine UK pregnancy supplements (folate, vitamin D) do NOT include calcium; the NHS expects you to meet this from food (dairy, fortified plant drinks, fortified bread / cereal, leafy greens). If your dietary intake is low or you exclude dairy, talk to your midwife or GP about whether supplementation is needed.
UK breastfeeding RNI rises to 1,250 mg/day because calcium goes into breast milk. Sustained low intake during prolonged breastfeeding can lead to maternal bone-mineral loss. Meet from food where possible; talk to your midwife or GP if you think your intake is low.
Talk to your GP, midwife, or pharmacist before starting any supplement during pregnancy or breastfeeding.
More clinical detail (for clinicians and informed readers)
Contraindications
- Hypercalcaemia (any cause — primary hyperparathyroidism, sarcoidosis, malignancy, vitamin D toxicity, milk-alkali syndrome, hypercalcaemia of immobilisation).
- Severe renal impairment without specialist input.
- Untreated kidney stones (specialist input required).
- Hypersensitivity to any component of the formulation.
Drug interactions
Levothyroxine (thyroid medication) · medium
Effect: Calcium binds to levothyroxine in the gut and reduces how much you absorb. Separate by ≥4 hours.
Mechanism: Calcium ions chelate the levothyroxine molecule in the intestinal lumen, preventing absorption.
Action: Tell your prescriber about your supplement routine if you take levothyroxine. Standard practice: levothyroxine first thing on rising, calcium with a later meal.
Source: BNF Levothyroxine + thyroid prescribing guidance
Tetracycline + fluoroquinolone antibiotics (doxycycline, ciprofloxacin, etc.) · medium
Effect: Calcium reduces absorption of these antibiotics; separate by ≥2 hours to maintain antibiotic effectiveness.
Mechanism: Chelation reduces antibiotic absorption.
Action: Tell your prescriber or pharmacist about your calcium supplement when you collect any antibiotic prescription.
Source: BNF tetracyclines + fluoroquinolones
Bisphosphonates (alendronate, risedronate, ibandronate, zoledronate) · medium
Effect: Calcium reduces bisphosphonate absorption substantially. Standard practice: bisphosphonate on rising, water only, wait 30+ minutes; calcium at a separate meal.
Mechanism: Direct chelation in the intestine reduces absorption to near-zero if taken simultaneously.
Action: Talk to your GP or pharmacist about the timing if you take a bisphosphonate for osteoporosis.
Source: BNF bisphosphonates + NICE CG146 osteoporosis
Iron supplements (ferrous sulphate, ferrous fumarate, ferrous bisglycinate) — competition at the same intestinal transporters; separate by ≥2 hours.
Thiazide diuretics (bendroflumethiazide, indapamide) — increased renal calcium retention; high-dose calcium can produce hypercalcaemia. Tell your prescriber.
Lithium — increased risk of hypercalcaemia. Tell your prescriber.
Digoxin — high serum calcium potentiates digoxin cardiac action; high-dose calcium is not advisable on digoxin. Tell your prescriber.
Proton pump inhibitors (omeprazole, lansoprazole, pantoprazole) — reduce stomach acid; calcium carbonate absorption impaired but calcium citrate absorption unaffected. Tell your pharmacist.
Zinc supplements — at very high zinc doses, competition for absorption; less clinically significant than iron.
Calcium-channel blockers (amlodipine, diltiazem, verapamil) — modest pharmacodynamic interaction at high calcium doses.
Aluminium-containing antacids — calcium increases aluminium absorption.
Tell your prescriber if you take any of these combinations. This is not personalised advice.
This is not an exhaustive list. Always tell your prescriber and pharmacist about every supplement you take.
Common side effects
- Constipation, GI bloating, stomach upset — particularly with calcium carbonate and at higher doses.
- Mild abdominal cramping or wind.
Rare side effects
- Hypercalcaemia (sustained excess intake or in conditions causing impaired calcium regulation).
- Kidney stones (high-dose supplemental calcium taken apart from meals).
- Milk-alkali syndrome (very high calcium plus alkaline antacids — historically common with bicarbonate-containing antacids).
- Allergic reaction (very rare).
How to take it
- Typical supplemental range
- UK supplements typically deliver 200-600 mg elemental calcium per serving. Bone-protective indications under NICE guidance (e.g. alongside bisphosphonate therapy) typically use 1000 mg/day total elemental calcium plus 800 IU vitamin D, with diet making up part of the total. Single-dose absorption saturates above ~500 mg elemental — split-dose 2×500 mg achieves better total uptake than a single 1000 mg dose.
- Timing
- Carbonate forms with food (stomach acid required). Citrate, lactate, gluconate forms with or without food. Split-dose 2×500 mg better absorbed than single 1000 mg. Separate by ≥2 hours from iron, levothyroxine, tetracycline, fluoroquinolone, and bisphosphonate.
How to spot quality
Look for
- Elemental calcium per serving stated on the front of the label — not just total calcium-salt weight.
- Form declared (carbonate, citrate, hydroxyapatite, lactate, gluconate, malate, formate).
- Vitamin D3 included as cofactor for absorption (typical co-formulation) — and ideally vitamin K2 for the bone-mineralisation directional axis.
- Per-serving elemental calcium ≤500 mg if a one-tablet-per-day format is used (above 500 mg per dose, single-dose absorption saturates and split dosing would achieve better total uptake).
- For marine-source preparations (coral / oyster shell): heavy-metal screen disclosed on spec sheet (lead in particular).
- GMP-certified manufacture.
Red flags
- Total calcium-salt weight on the front of the label without elemental calcium per serving — "1000 mg calcium" with no form declared could be 400 mg elemental from carbonate or 210 mg from citrate.
- Calcium without vitamin D in a bone-health-positioned product — vitamin D is the canonical absorption cofactor and the Article 14 disease-risk-reduction claim is specifically for calcium plus vitamin D.
- Coral / oyster-shell / "marine-source" calcium without a heavy-metal screen — historic lead-contamination concern.
- Dose schedule recommending more than 500 mg elemental calcium in a single take.
- Cardiovascular-prevention positioning of calcium-only supplements — outside UK NICE pathways and outside trial-evidence boundaries.
- "More is better" / "high-strength" calcium products at >1500 mg/day total — limited evidence of benefit, increasing evidence of risk.
Commonly combined with
Other ingredients that share a biological pathway, cofactor relationship, or evidence-backed protocol with this one. Mechanisms below cite primary physiology — not folk pairing. Doses are literature ranges, not recommendations. Talk to your pharmacist or GP before changing your stack, especially if you take prescription medication.
Vitamin D3
Strong evidenceThe canonical bone-health pairing — vitamin D regulates intestinal calcium absorption, and the UK Article 14 disease-risk-reduction claim for postmenopausal bone-mineral loss is specifically for the combination, not either alone.
Active intestinal calcium absorption is calcitriol-dependent. The active form of vitamin D (1,25-dihydroxyvitamin D, calcitriol) up-regulates the apical calcium-channel TRPV6 and the intracellular calcium-binding protein calbindin-D9k in duodenal enterocytes, increasing the regulated component of calcium uptake. At high luminal calcium concentrations the unregulated paracellular component dominates, but at normal dietary intakes the active fraction matters substantially.
The Article 14 reduction-of-disease-risk claim ("Calcium and vitamin D help to reduce the loss of bone mineral in postmenopausal women. Low bone mineral density is a risk factor for osteoporotic bone fractures") attaches to the combination at specific dose thresholds — neither calcium alone nor vitamin D alone carries the same disease-risk-reduction claim. UK NICE bone-health pathways for postmenopausal osteoporosis prescribe calcium plus vitamin D alongside bisphosphonate or other bone-protective drug.
Trial evidence is strongest for the bone-mineral and fragility-fracture endpoints in postmenopausal women on bone-protective drug treatment with low dietary calcium intake; trial evidence is weaker (and less consistent) for community-dwelling postmenopausal women without bone-protective drug treatment.
Evidence: UK NICE CG146 osteoporosis / CKS osteoporosis pathways prescribe calcium 1000 mg + vitamin D 800 IU alongside bisphosphonate treatment. Multiple RCTs and meta-analyses support the combined effect on bone-mineral density in this population. [2,3]
Doses studied: 1000 mg/day elemental calcium plus 800 IU (20 µg) vitamin D3 in postmenopausal bone-health pathway. Lower-dose maintenance combinations (500 mg/day plus 400 IU) appear in mainstream UK supplement market.
Vitamin K2 (Menaquinone)
Mixed evidenceThe "directional bone mineralisation" pairing — K2 cofactors osteocalcin γ-carboxylation (depositing calcium into bone matrix) and matrix Gla protein γ-carboxylation (inhibiting vascular calcification). Co-formulated to direct calcium into bone, not arteries.
Vitamin K (specifically the menaquinone forms — K2) is the cofactor for γ-glutamyl carboxylase, which post-translationally activates the Gla-domain proteins osteocalcin (in bone osteoblasts) and matrix Gla protein (in vascular smooth-muscle cells). The activated proteins then bind calcium ions: osteocalcin directs calcium into hydroxyapatite mineralisation in bone; matrix Gla protein binds and removes calcium from vascular smooth-muscle, inhibiting arterial calcification.
The mechanism is the basis for the "calcium plus D3 plus K2" co-formulation rationale: vitamin D drives calcium absorption from the gut; vitamin K2 directs the absorbed calcium toward bone matrix (via osteocalcin) and away from arterial walls (via MGP). Without adequate K2, both processes are impaired.
Trial evidence on hard cardiovascular endpoints (myocardial infarction, cardiovascular mortality, fragility fracture) from the K2-plus-calcium-plus-D3 combination is still developing — Knapen 2015 (Thromb Haemost) on long-term K2 MK-7 and arterial stiffness in postmenopausal women, and observational cohorts (Rotterdam Study, Beulens 2009) on dietary K2 and coronary calcification, are the most-cited references. The "directional mineralisation" framing is mechanistically robust; the clinical-endpoint evidence is moderate not strong.
Evidence: Calcium-K2 combination bone trials conflict: Moschonis 2011 (calcium + D3 + K2 fortified dairy) found additional lumbar-spine BMD benefit over control, while Zhang 2020 found K2 + calcium + D3 gave no benefit beyond K2 alone. The vascular "directional mineralisation" rationale rests on K2-alone (Knapen 2015) and observational data (Rotterdam, Beulens 2009) — no combination RCT on hard cardiovascular endpoints. [15,16]
Doses studied: 500-1000 mg/day elemental calcium with 800-2000 IU vitamin D3 and 90-180 µg vitamin K2 (predominantly MK-7 form for half-life). NB-476 Vitamin D3+K2 covers the K2-and-D3 components without delivering calcium.
Found in Camden: Weekly Vitamin D3 3000IU + K2 MK-7 90 Capsules
Magnesium
Moderate evidenceCalcium-magnesium balance is fundamental to bone, muscle, and neuromuscular function. Both minerals are cofactors in PTH and vitamin D metabolism; magnesium deficiency impairs calcium homeostasis.
Magnesium is required as a cofactor for parathyroid hormone (PTH) secretion and for the conversion of 25-OH-D to active 1,25-(OH)₂-D (calcitriol). Severe magnesium deficiency therefore impairs the active form of vitamin D and the regulated component of calcium absorption — a magnesium-deficient adult cannot fully use a calcium supplement until magnesium is restored.
Calcium and magnesium also act as physiological antagonists at smooth muscle cells: calcium drives contraction, magnesium drives relaxation. The balance is the basis for the magnesium-as-muscle-relaxant pairing alongside calcium for muscle-cramp / restless-leg framings — though trial evidence for routine combined supplementation in muscle cramp is limited.
Co-formulation considerations: at very high doses calcium and magnesium compete for absorption at the same divalent-cation transporters; at standard supplement doses (400-500 mg calcium + 200-300 mg magnesium per serving) the competition is not clinically significant. The pairing is also bone-health-additive — magnesium contributes ~60% of bone mineral content alongside calcium hydroxyapatite, with a separate UK Article 13.1 authorised claim ("Magnesium contributes to the maintenance of normal bones").
Evidence: Magnesium-PTH and magnesium-calcitriol mechanisms well established (Rude 2009; National Academies). UK Article 13.1 claim for magnesium and bones supports the pairing on a regulatory basis. Trial evidence for combined calcium-magnesium supplementation on hard endpoints (fracture, cramp resolution) is limited. [6]
Doses studied: 500-1000 mg/day calcium with 200-400 mg/day magnesium. NB-500 Magnesium Complex covers the magnesium component.
Found in Camden: Aurifera™ Magnesium Complex 120 Capsules
Collagen
Limited evidenceBone matrix is ~70% mineral and ~30% organic — mostly type I collagen. Calcium provides the mineral; collagen provides the scaffold the mineral is laid into.
Bone is a composite material: the inorganic phase is calcium hydroxyapatite (Ca₁₀(PO₄)₆(OH)₂) accounting for roughly 70% of bone mass, and the organic phase is mostly type I collagen accounting for roughly 30%. Mineralisation occurs onto the collagen scaffold during bone formation; mineral can be drawn from the matrix during resorption.
Hydrolysed collagen peptide supplementation (typically 5-10 g/day) has been studied for postmenopausal bone-mineral density (König 2018 Nutrients; Argyrou 2020 J Musculoskelet Neuronal Interact) with modest signals on BMD and bone-turnover markers. UK NICE bone-health pathway does not include collagen; the regulatory tier is food supplement with no UK-authorised bone claim for collagen.
The combination is mechanistically coherent — providing both the mineral and the organic-scaffold substrate — but the trial evidence is concentrated on each component separately. Camden's collagen entry carries the collagen-specific detail.
Evidence: König 2018 and Argyrou 2020 RCTs on hydrolysed collagen peptide and postmenopausal BMD are the most-cited combination-relevant trials. UK NICE pathway does not list collagen.
Doses studied: 500-1000 mg/day calcium with 5-10 g/day hydrolysed collagen peptide.
Verifera™ editorial perspective
Why it matters. Calcium is one of the highest-volume search clusters in consumer supplement research — particularly the "best calcium for bones" cluster, the "calcium carbonate vs citrate" cluster, and the contested cardiovascular safety cluster (Bolland 2010 BMJ meta-analysis). The Verifera editorial position is that this entry needs to be honest about the food-first NHS framing (most UK adults can meet calcium needs from diet), surface the elemental-calcium- per-serving point that most marketing buries, and place the cardiovascular debate in proper NICE-pathway context.
Where Camden lands. Camden Medicals does NOT currently retail a single-active calcium SKU; calcium often appears as part of multi-ingredient bone-support formulations alongside vitamin D3 + magnesium + vitamin K2. This entry exists as the UK-anchored reference for the bone-health nutrient cluster.
If you want to explore further. For bone health: NHS Eatwell-Guide-aligned diet review first — milk, fortified plant drinks, leafy greens, tinned fish with bones, fortified bread / cereal. Most UK adults meet calcium needs from food. For postmenopausal women and older adults with low dietary intake or osteoporosis: UK NICE CG146 / CKS Osteoporosis pathway via GP — calcium + vitamin D supplementation alongside any prescribed bone-protective medicine. Pregnancy: 700 mg/day same as non-pregnant adult RNI; talk to your midwife if your dietary intake is low.
How this entry was researched
Authoritative sources consulted:
- NHS calcium + vitamin D pages + Eatwell Guide
- NICE CG146 (Osteoporosis: assessing the risk of fragility fracture) + CKS Osteoporosis Prevention
- BNF calcium + vitamin D + alendronic acid
- GB Nutrition and Health Claims (NHC) Register — multiple Article 13.1 authorised claims + Article 14 disease-risk-reduction claim
- UK SACN reports on vitamin D and bone health
- EFSA tolerable upper intake levels
- PubMed (via E-utilities MCP)
PubMed search terms:
Bolland calcium supplementation cardiovascular meta-analysis
Literature search date: 2026-05-12
Sources listed are those consulted by the Verifera™ editorial team. Readers should verify against current authoritative sources.